Contact this trialFirst, we need to learn more about you.
Androgen Receptor Inhibitor
PSMA PET Scan-Directed Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial studies how well a PET scan using fluciclovine helps to detect prostate cancer and if site-directed treatment to abnormalities found on the scan works well for treating patients with prostate cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service